semaglutide oral obesity VisualAbstract:Oral effectively reduces bodyweight in non-diabetic adults with Oral Semaglutide 25 mg and

How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test may help provide context for individual variation in GLP-1 medication response by examining genetic predispositions in key peptide pathways, including GLP1R rs6923761, GIPR rs1800437, and FTO rs9939609 variants

Prioritize sleep and stress management: Poor sleep and high stress can impact hormones that control weight

The recently introduced peptides GLP1/GIP medication can be administered once weekly and have demonstrated substantially improved weight-losing effects within a tolerable safety margin in a series of STEP and SURPASS trials

A total of six libraries (control group and medium-concentration addition group, each with three replicates) were constructed and performed on the NovaSeq 6000 platform using the NovaSeq reagent kit

High Purity: Lyophilized Semaglutide is processed to ensure maximum peptide purity and zero additives before reconstitution